Sign in

CIK 0001703057 · Large accelerated filer

AbCellera Biologics Inc.

Sign in to watch
Ticker
ABCL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(604) 559-9005
Business address
150 W 4TH AVENUE, VANCOUVER, British Columbia, Canada, V5Y 1G6
  1. 4 Open-market sale Chief Legal Officer sold 1,000,000 shares at $25.50 ($25,500,000)
  2. 4 Open-market sale Chief Technology Officer sold 1,000,000 shares at $25.50 ($25,500,000)
  3. 4 Open-market sale Chief Financial Officer sold 1,200,000 shares at $25.50 ($30,600,000)
  4. 4 Option exercise Chief Legal Officer acquired 1,000,000 shares (option exercise)
  5. 4 Option exercise Chief Financial Officer acquired 1,200,000 shares (option exercise)
  6. 4 Option exercise Chief Technology Officer acquired 1,000,000 shares (option exercise)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Conversion 10% owner acquired 29,105,761 shares (conversion)
  9. 3/A Insider 3/A
  10. 4 Open-market buy Director bought 3,000,000 shares at $20.00 ($60,000,000)
  11. 4 Conversion Director acquired 29,105,761 shares (conversion)
  12. 4 Open-market buy Director bought 25,000 shares at $20.00 ($500,000)
  13. 4 Open-market buy Chief Operating Officer bought 23,000 shares at $20.00 ($460,000)
  14. 4 Open-market buy Director bought 73,665 shares at $20.00 ($1,473,300)
  15. 4 Open-market buy Chief Legal Officer bought 500 shares at $20.00 ($10,000)
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 7 of 8 · 145 filings